These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Characterization of a Bivalent Vaccine Capable of Inducing Protection Against Both Ebola and Cross-clade H5N1 Influenza in Mice. Wong G; Qiu X; Ebihara H; Feldmann H; Kobinger GP J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S435-42. PubMed ID: 26022441 [TBL] [Abstract][Full Text] [Related]
14. Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses. Geisbert TW; Daddario-Dicaprio KM; Geisbert JB; Reed DS; Feldmann F; Grolla A; Ströher U; Fritz EA; Hensley LE; Jones SM; Feldmann H Vaccine; 2008 Dec; 26(52):6894-900. PubMed ID: 18930776 [TBL] [Abstract][Full Text] [Related]
15. A Replicating Single-Cycle Adenovirus Vaccine Against Ebola Virus. Anguiano-Zarate SS; Matchett WE; Nehete PN; Sastry JK; Marzi A; Barry MA J Infect Dis; 2018 Nov; 218(12):1883-1889. PubMed ID: 29982595 [TBL] [Abstract][Full Text] [Related]
16. The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial. Huttner A; Dayer JA; Yerly S; Combescure C; Auderset F; Desmeules J; Eickmann M; Finckh A; Goncalves AR; Hooper JW; Kaya G; Krähling V; Kwilas S; Lemaître B; Matthey A; Silvera P; Becker S; Fast PE; Moorthy V; Kieny MP; Kaiser L; Siegrist CA; Lancet Infect Dis; 2015 Oct; 15(10):1156-1166. PubMed ID: 26248510 [TBL] [Abstract][Full Text] [Related]